These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9852284)

  • 21. Preparation and characterization of a bifunctionally spin-labeled mutant of murine epidermal growth factor for saturation-transfer electron paramagnetic resonance studies of the growth factor/receptor complex.
    Rousseau DL; Guyer CA; Beth AH; Papayannopoulos IA; Wang B; Wu R; Mroczkowski B; Staros JV
    Biochemistry; 1993 Aug; 32(31):7893-903. PubMed ID: 8394119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iodination of mouse EGF with chloramine T at 4 degrees C: characterization of the iodinated peptide and comparison with other labelling methods.
    Wouters-Ballman P; Donnay I; Devleeschouwer N; Verstegen J
    J Recept Signal Transduct Res; 1995 Apr; 15(5):737-46. PubMed ID: 8747883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Processing and transfer of epidermal growth factor in developing rat jejunum and ileum.
    Rao RK; Koldovský O; Korc M; Pollack PF; Wright S; Davis TP
    Peptides; 1990; 11(6):1093-102. PubMed ID: 2087434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative experimental/theoretical studies on the EGFR dimerization under the effect of EGF/EGF analogues binding: Highlighting the importance of EGF/EGFR interactions at site III interface.
    Mehrabi M; Mahdiuni H; Rasouli H; Mansouri K; Shahlaei M; Khodarahmi R
    Int J Biol Macromol; 2018 Aug; 115():401-417. PubMed ID: 29665393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-function studies of murine epidermal growth factor: expression and site-directed mutagenesis of epidermal growth factor gene.
    Ray P; Moy FJ; Montelione GT; Liu JF; Narang SA; Scheraga HA; Wu R
    Biochemistry; 1988 Sep; 27(19):7289-95. PubMed ID: 2849989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of 125I after administration of 125I-EGF-dextran, 125I-EGF or 125I to human bladder cancer spheroids.
    Sjöström A; Bue P; Malmstrom P; Carlsson J
    Int J Oncol; 2000 Sep; 17(3):559-64. PubMed ID: 10938398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the mechanisms involved in the regulation of the cell-surface receptors for human choriogonadotropin and mouse epidermal growth factor in cultured Leydig tumor cells.
    Lloyd CE; Ascoli M
    J Cell Biol; 1983 Feb; 96(2):521-6. PubMed ID: 6300136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting malignant glioma cells in vitro using platelet-derived growth factor AA-based conjugates.
    Wester MD; Wasteson A; Lindström A
    J Drug Target; 2009 May; 17(4):268-77. PubMed ID: 19255898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformational characterization of a single-site mutant of murine epidermal growth factor (EGF) by 1H NMR provides evidence that leucine-47 is involved in the interactions with the EGF receptor.
    Moy FJ; Scheraga HA; Liu JF; Wu R; Montelione GT
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9836-40. PubMed ID: 2690076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential of radiolabeled EGF-dextran conjugates in the treatment of urinary bladder carcinoma.
    Bue P; Márquez M; Malmström PU; Westlin JE; Nilsson S; Holmberg AR
    Cancer; 1997 Dec; 80(12 Suppl):2385-9. PubMed ID: 9406687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors.
    Capala J; Barth RF; Bendayan M; Lauzon M; Adams DM; Soloway AH; Fenstermaker RA; Carlsson J
    Bioconjug Chem; 1996; 7(1):7-15. PubMed ID: 8741985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of dextranation on the uptake of peptides in micrometastases: studies on binding of EGF in tumor spheroids.
    Nilsson P; Gedda L; Sjöström A; Carlsson J
    Tumour Biol; 2001; 22(4):229-38. PubMed ID: 11399948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uptake of a boronated epidermal growth factor-dextran conjugate in CHO xenografts with and without human EGF-receptor expression.
    Olsson P; Gedda L; Goike H; Liu L; Collins VP; Pontén J; Carlsson J
    Anticancer Drug Des; 1998 Jun; 13(4):279-89. PubMed ID: 9627668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retention of biologic activity of human epidermal growth factor following conjugation to a blood-brain barrier drug delivery vector via an extended poly(ethylene glycol) linker.
    Deguchi Y; Kurihara A; Pardridge WM
    Bioconjug Chem; 1999; 10(1):32-7. PubMed ID: 9893961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal growth factor receptor binding and biological activity in the ovary of goldfish, Carassius auratus.
    Pati D; Balshaw K; Grinwich DL; Hollenberg MD; Habibi HR
    Am J Physiol; 1996 May; 270(5 Pt 2):R1065-72. PubMed ID: 8928907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies with insulin and insulin-like growth factor-I show that the increased labeling of phosphatidylinositol-3,4-bisphosphate is not sufficient to elicit the diverse actions of epidermal growth factor on MA-10 Leydig tumor cells.
    Pignataro OP; Ascoli M
    Mol Endocrinol; 1990 May; 4(5):758-65. PubMed ID: 2177144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent.
    Barth RF; Wu G; Yang W; Binns PJ; Riley KJ; Patel H; Coderre JA; Tjarks W; Bandyopadhyaya AK; Thirumamagal BT; Ciesielski MJ; Fenstermaker RA
    Appl Radiat Isot; 2004 Nov; 61(5):899-903. PubMed ID: 15308165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled proteolysis of mouse epidermal growth factor. An RP-HPLC and 1H-n.m.r. study.
    Menegatti E; Scalia S; Bortolotti F; Ascenzi P; De Marco A
    Int J Pept Protein Res; 1989 Sep; 34(3):161-5. PubMed ID: 2689368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells.
    Uckun FM; Narla RK; Jun X; Zeren T; Venkatachalam T; Waddick KG; Rostostev A; Myers DE
    Clin Cancer Res; 1998 Apr; 4(4):901-12. PubMed ID: 9563884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal growth factor-dependent dissociation of CrkII proto-oncogene product from the epidermal growth factor receptor in human glioma cells.
    Katayama H; Hashimoto Y; Kiyokawa E; Nakaya M; Sakamoto A; Machinami R; Kurata T; Mochizuki N; Matsuda M
    Jpn J Cancer Res; 1999 Oct; 90(10):1096-103. PubMed ID: 10595738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.